CAS 1286279-29-5

BMS-813160

CAS: 1286279-29-5

BMS-813160

Fórmula: C₂₅H₄₀N₈O₂

Pureza: ≥98%

Peso molecular: 484.64

Ref: 54-BUP08645

BMS-813160

CAS: 1286279-29-5

BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.

Fórmula: C₂₅H₄₀N₈O₂

Pureza: 99.66% - 99.79%

Cor e Forma: Solid

Peso molecular: 484.64

Ref: TM-T4584

BMS-813160

CAS: 1286279-29-5

N-((1R,2S,5R)-2-((S)-3-((7-(tert-Butyl)pyrazolo[1,5-a][1,3,5]triazin-4-yl)amino)-2-oxopyrrolidin-1-yl)-5-(tert-butylamino)cyclohexyl)acetamide

Fórmula: C₂₅H₄₀N₈O₂

Pureza: 99%

Peso molecular: 484.64

Ref: IN-DG00809592

BMS 813160

CAS: 1286279-29-5

Antagonist of chemokine receptors CCR2 and CCR5

Fórmula: C₂₅H₄₀N₈O₂

Pureza: Min. 95%

Peso molecular: 484.64 g/mol

Ref: 3D-BB164193